Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation.
about
Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Flecainide-metoprolol combinat ...... mptomatic atrial fibrillation.
@en
Flecainide-metoprolol combinat ...... mptomatic atrial fibrillation.
@nl
type
label
Flecainide-metoprolol combinat ...... mptomatic atrial fibrillation.
@en
Flecainide-metoprolol combinat ...... mptomatic atrial fibrillation.
@nl
prefLabel
Flecainide-metoprolol combinat ...... mptomatic atrial fibrillation.
@en
Flecainide-metoprolol combinat ...... mptomatic atrial fibrillation.
@nl
P2093
P2860
P356
P1433
P1476
Flecainide-metoprolol combinat ...... mptomatic atrial fibrillation.
@en
P2093
Alessandro Capucci
Domenico Gabrielli
Federico Guerra
Jenny Ricciotti
Luca Piangerelli
P2860
P304
P356
10.1093/EUROPACE/EUV462
P577
2016-02-17T00:00:00Z